Skip to search.
 TSX Down 0.39% TSX Ventures Up 0.28%

Agenus Inc. (AGEN)

-NasdaqCM
4.89 Up 0.21(4.49%) Mar 27, 4:00PM EDT
|After Hours : 4.90 Up 0.01 (0.20%) Mar 27, 5:05PM EDT
Add to Portfolio
Prev Close:4.68
Open:4.71
Bid:4.75 x 1500
Ask:4.93 x 300
1y Target Est:9.25
Beta:1.05
Earnings Date:May 6 - May 11 (Est.)
Day's Range:4.70 - 4.90
52wk Range:2.27 - 6.49
Volume:871,538
Avg Vol (3m):2,136,350
Market Cap:346.01M
P/E (ttm):N/A
EPS (ttm):-0.71
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGENUp 4.49%346.01M
ABPIUp 3.45%N/A
DNDN 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):47.46
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.40
Quarterly EPS Est (Mar-15) :-0.01
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., an immunotherapy company, engages in discovering and developing innovative treatments for patients with cancer and other diseases. Its treatments focus on providing therapeutic benefit through modulation of immune function. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback